Tm Bioscience to Supply St. Joseph's Hospital with Tag-It™ Reagents
News Feb 16, 2006
"We selected Tm's Tag-It™ platform because we were impressed by its performance and flexibility. Tm's technology has allowed us to develop an assay testing for numerous CF associated mutations at once in a single well, an extremely time-efficient and cost-effective solution," said John Stone, Director of Laboratory Services at St. Joseph's Hospital.
"Because the platform is open and flexible, we ultimately anticipate providing our patients with a broader menu of important genetic tests using Tm reagents."
"We look forward to working with St. Joseph's Hospital to provide leading edge medical laboratory services for the state of Arizona," said Greg Hines, President and CEO of Tm Bioscience.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019